Global Chemiluminescence Immunoassay Market Size Study & Forecast, by Product (Instruments, Consumables), Sample Type (Blood, Urine), Application, End-use and Regional Forecasts 2025-2035

The Global Chemiluminescence Immunoassay (CLIA) Market, valued at approximately USD 12.25 billion in 2024, is set to expand at a compelling CAGR of 4.60% during the forecast period from 2025 to 2035. Chemiluminescence immunoassay, a sophisticated diagnostic technology that utilizes the emission of light from a chemical reaction to detect the presence of specific antigens or antibodies, has become a cornerstone in clinical laboratories due to its unparalleled sensitivity, specificity, and throughput capabilities. This technique is increasingly being adopted across a wide spectrum of applications—from infectious disease diagnostics and oncology to endocrinology and cardiovascular disease detection—owing to its ability to deliver rapid, precise, and reproducible results. The acceleration in demand is largely driven by the global rise in chronic and infectious diseases, coupled with the growing emphasis on early and accurate diagnosis as part of precision medicine initiatives.

Rising healthcare expenditure, the integration of automated analyzers, and continuous technological innovations in assay kits are further propelling market expansion. Laboratories and hospitals worldwide are transitioning from traditional immunoassay methods to CLIA-based systems due to their operational efficiency and cost-effectiveness in high-volume testing environments. For example, the surge in biomarker-based screening programs and the increased adoption of CLIA in point-of-care testing are reshaping diagnostic pathways, reducing turnaround times, and enhancing patient outcomes. Nevertheless, market growth may encounter restraints in the form of high equipment costs and the need for skilled personnel to operate advanced analyzers, especially in resource-limited healthcare settings.

From a regional standpoint, North America currently holds the lion’s share of the CLIA market, supported by its mature healthcare infrastructure, robust reimbursement framework, and strong presence of industry leaders investing heavily in R&D for assay innovation. Europe follows closely, driven by a rising demand for specialized diagnostics, favorable government screening programs, and a growing geriatric population susceptible to chronic conditions. Meanwhile, the Asia Pacific region is anticipated to register the fastest growth through 2035, fueled by rapid healthcare modernization, increasing laboratory automation, and a surge in awareness around preventive diagnostics in countries such as China, India, and Japan. Emerging markets in Latin America and the Middle East & Africa are also making headway as they expand laboratory networks, enhance diagnostic capabilities, and attract private investments into healthcare infrastructure.

Major market player included in this report are:
• Abbott Laboratories
• Siemens Healthineers AG
• F. Hoffmann-La Roche Ltd.
• Beckman Coulter, Inc.
• BioMérieux SA
• Thermo Fisher Scientific Inc.
• Ortho Clinical Diagnostics
• Danaher Corporation
• Mindray Medical International Limited
• DiaSorin S.p.A.
• Sysmex Corporation
• Agilent Technologies, Inc.
• Randox Laboratories Ltd.
• QuidelOrtho Corporation
• Becton, Dickinson and Company

Global Chemiluminescence Immunoassay Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Product:
• Instruments
• Consumables

By Sample Type:
• Blood
• Urine

By Application:
• Infectious Diseases
• Oncology
• Endocrinology
• Cardiology
• Others

By End-use:
• Hospitals
• Diagnostic Laboratories
• Research & Academic Institutes
• Others

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more